BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAE1. A total of 35 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q1 2014. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $4,847,000 | -87.9% | 4,585,000 | -88.2% | 0.03% | -86.3% |
| Q1 2018 | $39,954,000 | -5.7% | 39,006,000 | +0.0% | 0.25% | -83.9% |
| Q4 2017 | $42,368,000 | -3.3% | 39,002,000 | -0.3% | 1.55% | -5.0% |
| Q3 2017 | $43,821,000 | +1.0% | 39,125,000 | +0.3% | 1.63% | -11.2% |
| Q2 2017 | $43,381,000 | -1.0% | 38,993,000 | +0.9% | 1.84% | -7.9% |
| Q1 2017 | $43,803,000 | +0.9% | 38,633,000 | -0.1% | 1.99% | -3.8% |
| Q4 2016 | $43,417,000 | -2.8% | 38,676,000 | +4.2% | 2.07% | +2.9% |
| Q3 2016 | $44,673,000 | +7.8% | 37,111,000 | -0.2% | 2.01% | -2.5% |
| Q2 2016 | $41,455,000 | +2.5% | 37,179,000 | +6.9% | 2.06% | -6.3% |
| Q1 2016 | $40,433,000 | -10.2% | 34,782,000 | -0.5% | 2.20% | -9.9% |
| Q4 2015 | $45,034,000 | +43.4% | 34,962,000 | +44.2% | 2.45% | +49.3% |
| Q3 2015 | $31,411,000 | -16.8% | 24,239,000 | -0.7% | 1.64% | -15.2% |
| Q2 2015 | $37,732,000 | +6.7% | 24,419,000 | +3.0% | 1.93% | +3.2% |
| Q1 2015 | $35,365,000 | +24.5% | 23,703,000 | -1.6% | 1.87% | +27.9% |
| Q4 2014 | $28,415,000 | +10.1% | 24,092,000 | -0.8% | 1.46% | +9.7% |
| Q3 2014 | $25,802,000 | +1.6% | 24,283,000 | -0.7% | 1.34% | -4.6% |
| Q2 2014 | $25,390,000 | -8.3% | 24,457,000 | -2.9% | 1.40% | +0.3% |
| Q1 2014 | $27,679,000 | +3.7% | 25,176,000 | +0.2% | 1.40% | +38.8% |
| Q4 2013 | $26,700,000 | – | 25,114,000 | – | 1.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ferox Capital Management LP | 6,000,000 | $6,271,000 | 4.60% |
| Weiss Asset Management LP | 27,058,000 | $28,040,000 | 2.16% |
| Birch Grove Capital LP | 4,643,000 | $4,802,000 | 1.91% |
| CSS LLC/IL | 20,256,000 | $20,993,000 | 0.89% |
| PIPER SANDLER & CO. | 1,000,000 | $1,036,000 | 0.86% |
| AQR Arbitrage LLC | 24,825,000 | $25,686,000 | 0.30% |
| CAPSTONE INVESTMENT ADVISORS, LLC | 17,000,000 | $17,589,000 | 0.20% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 5,000,000 | $5,182,000,000 | 0.12% |
| PALISADE CAPITAL MANAGEMENT, LP | 4,107,000 | $4,256,000 | 0.12% |
| Verition Fund Management LLC | 3,106,000 | $3,214,000 | 0.12% |